International Journal of Hyperthermia (Jan 2019)

Using microwave thermal ablation to develop a subtotal, cortical-sparing approach to the management of primary aldosteronism

  • Padraig T. Donlon,
  • Hojjatollah Fallahi,
  • Warren L. Beard,
  • Atif Shahzad,
  • Lindsay Heflin,
  • Whitney Cox,
  • Brooke Bloomberg,
  • James D. Lillich,
  • Chanran K. Ganta,
  • Gerard J. O’Sullivan,
  • Giuseppe Ruvio,
  • Paula M. O’Shea,
  • Martin O’Halloran,
  • Punit Prakash,
  • Michael Conall Dennedy

DOI
https://doi.org/10.1080/02656736.2019.1650205
Journal volume & issue
Vol. 36, no. 1
pp. 904 – 913

Abstract

Read online

Objective: To investigate the feasibility and efficacy of localized, subtotal, cortical-sparing microwave thermal ablation (MTA) as a potential curative management for primary aldosteronism. The study investigated with equal importance the selected ablation of small volumes of adrenal cortex while sparing adjacent cortex. Method: An in-vivo study was carried out in swine (n = 8) where MTA was applied under direct visualization, to the adrenal glands at 45 W or 70 W for 60 s, using a lateral, side-firing probe and a non-penetrative approach. Animals were survived for 48 h post-procedurally. Animals were investigated for markers of histological, immunohistochemical and biochemical evidence of adrenal function and adrenal damage by assessing samples drawn intra-operatively and at the time of euthanasia. Results: Selected MTA (70 W for 60 s) successfully ablated small adrenocortical volumes (∼0.8 cm3) characterized by coagulative necrosis and abnormal expression of functional markers (CYP11B1 and CYP17). Non-ablated, adjacent cortex was not affected and preserved normal expression of functional markers, without increased expression of markers of heat damage (HSP-70 and HMGB-1). Limited adrenal medullary damage was demonstrated histologically, clinically and biochemically. Conclusion: MTA offers potential as an efficient methodology for delivering targeted subtotal cortical-sparing adrenal ablation. Image-guided targeted MTA may also represent a safe future modality for curative management of PA, in the setting of both unilateral and bilateral disease.

Keywords